These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 29411759)

  • 21. [Specific immunotherapy in the treatment of patients with atopic dermatitis--results of double blind placebo controlled study].
    Silny W; Czarnecka-Operacz M
    Pol Merkur Lekarski; 2006 Dec; 21(126):558-65. PubMed ID: 17405298
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The ACVD task force on canine atopic dermatitis (XXIV): allergen-specific immunotherapy.
    Griffin CE; Hillier A
    Vet Immunol Immunopathol; 2001 Sep; 81(3-4):363-83. PubMed ID: 11553398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Allergen-specific immunotherapy induces monocyte-derived dendritic cells but attenuates their maturation and cytokine production in the lesional skin of an atopic dermatitis mouse model.
    Feng S; Song G; Liu L; Liu W; Liang G; Song Z
    J Dermatol; 2022 Dec; 49(12):1310-1319. PubMed ID: 36117445
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Production of a chimeric allergen derived from the major allergen group 1 of house dust mite species in Nicotiana benthamiana.
    Li C; Jiang Y; Guo W; Liu Z
    Hum Immunol; 2013 May; 74(5):531-7. PubMed ID: 23354320
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of one-year subcutaneous and sublingual immunotherapy on clinical and laboratory parameters in children with rhinitis and asthma: a randomized, placebo-controlled, double-blind, double-dummy study.
    Yukselen A; Kendirli SG; Yilmaz M; Altintas DU; Karakoc GB
    Int Arch Allergy Immunol; 2012; 157(3):288-98. PubMed ID: 22041501
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical significance of allergen specific immunotherapy in adult house-dust-mite-sensitive bronchial asthma: impact on disease severity and medical cost].
    Nagata M; Tabe K; Yamamoto H; Sakamoto Y; Matsuo H
    Arerugi; 1999 Dec; 48(12):1316-21. PubMed ID: 10666919
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contact allergy in atopic individuals in relation to allergen-specific immunotherapy.
    Siemund I; Hindsén M; Netterlid E; Güner N; Bruze M
    Eur J Dermatol; 2016 Jun; 26(3):271-80. PubMed ID: 27193374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ASIT therapy: advantages and adverse effects. own results and literature data.
    Besh OM; Besh DI; Sorokopud OO; Kondratiuk MO; Slaba OR
    Wiad Lek; 2018; 71(2 pt 1):341-345. PubMed ID: 29729170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Analysis of adverse reactions induced by subcutaneous immunotherapy against dust mite allergy in 234 cases with allergic rhinitis and asthma].
    Li MR; Wang XN; Jiang HD; Wang QY; Li YC; Lin J; Jin K; Zhang HL; Li CC
    Zhonghua Er Ke Za Zhi; 2012 Oct; 50(10):726-31. PubMed ID: 23302557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. House dust mite sublingual immunotherapy is safe and appears to be effective in moderate, persistent asthma.
    Wang L; Yin J; Fadel R; Montagut A; de Beaumont O; Devillier P
    Allergy; 2014 Sep; 69(9):1181-8. PubMed ID: 25056584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of subcutaneous allergen immunotherapy in atopic dogs: A retrospective study of 664 cases.
    Fennis EEM; van Damme CMM; Schlotter YM; Sinke JD; Leistra MHG; Bartels RT; Broere F
    Vet Dermatol; 2022 Aug; 33(4):321-e75. PubMed ID: 35635279
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Placebo effect in clinical trials with allergen-specific immunotherapy with inhalant allergens].
    Wedi B; Wieczorek D; Kapp A
    Hautarzt; 2017 Apr; 68(4):297-306. PubMed ID: 28194483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progress in the development of specific immunotherapies for house dust mite allergies.
    Moingeon P
    Expert Rev Vaccines; 2014 Dec; 13(12):1463-73. PubMed ID: 25187166
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Immunotherapy effect of ploypeptide vaccine of allergen group 1 from Dermatophagoides farinae on asthma mice].
    Song HY; Duan BB; Li CP
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2015 Oct; 27(5):490-6. PubMed ID: 26930933
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the long-term efficacy of 3- and 5-year house dust mite allergen immunotherapy.
    Stelmach I; Sobocińska A; Majak P; Smejda K; Jerzyńska J; Stelmach W
    Ann Allergy Asthma Immunol; 2012 Oct; 109(4):274-8. PubMed ID: 23010234
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A pilot study of the effect of pullulan-conjugated Der f 2 allergen-specific immunotherapy on canine atopic dermatitis.
    Kawano K; Mizuno T
    Vet Dermatol; 2017 Dec; 28(6):583-e141. PubMed ID: 28776792
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and immunologic effects of sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, randomized, placebo-controlled study.
    Lue KH; Lin YH; Sun HL; Lu KH; Hsieh JC; Chou MC
    Pediatr Allergy Immunol; 2006 Sep; 17(6):408-15. PubMed ID: 16925685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical improvement and immunological changes in atopic dermatitis patients undergoing subcutaneous immunotherapy with a house dust mite allergoid: a pilot study.
    Bussmann C; Maintz L; Hart J; Allam JP; Vrtala S; Chen KW; Bieber T; Thomas WR; Valenta R; Zuberbier T; Sager A; Novak N
    Clin Exp Allergy; 2007 Sep; 37(9):1277-85. PubMed ID: 17845407
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successful management of mite-allergic asthma with modified extracts of Dermatophagoides pteronyssinus and Dermatophagoides farinae in a double-blind, placebo-controlled study.
    García-Robaina JC; Sánchez I; de la Torre F; Fernández-Caldas E; Casanovas M
    J Allergy Clin Immunol; 2006 Nov; 118(5):1026-32. PubMed ID: 17088125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. House dust mite and cockroach exposure are strong risk factors for positive allergy skin test responses in the Childhood Asthma Management Program.
    Huss K; Adkinson NF; Eggleston PA; Dawson C; Van Natta ML; Hamilton RG
    J Allergy Clin Immunol; 2001 Jan; 107(1):48-54. PubMed ID: 11149990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.